| FDA backs Affymax and Takeda drug Omontys for anemia due to CKD - The Pharma Letter |
|
|
Keywords: Affymax, Takeda, Omontys, Peginesatide, Anemia, Kidney disease, CKD, USA, FDA Article | 28 March 2012 The US Food and Drug Administration yesterday approved Omontys (peginesatide, formerly known as Hematide) Injection for the treatment of anemia ... Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe. |